Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Short term Debt: 2019-2021

Historic Short term Debt for Pharming Group N.V (PHAR) over the last 3 years, with Dec 2021 value amounting to $171,593.

  • Pharming Group N.V's Short term Debt fell 62.95% to $143,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $143,000, marking a year-over-year decrease of 62.95%. This contributed to the annual value of $171,593 for FY2021, which is 99.31% down from last year.
  • Latest data reveals that Pharming Group N.V reported Short term Debt of $171,593 as of FY2021, which was down 99.31% from $25.0 million recorded in FY2020.
  • Over the past 5 years, Pharming Group N.V's Short term Debt peaked at $25.0 million during FY2020, and registered a low of $171,593 during FY2021.
  • Its 3-year average for Short term Debt is $15.1 million, with a median of $20.0 million in 2019.
  • Its Short term Debt has fluctuated over the past 5 years, first grew by 25.00% in 2020, then plummeted by 99.31% in 2021.
  • Yearly analysis of 3 years shows Pharming Group N.V's Short term Debt stood at $20.0 million in 2019, then climbed by 25.00% to $25.0 million in 2020, then crashed by 99.31% to $171,593 in 2021.